In this enlightening discussion, Ezekiel Emanuel, an oncologist and healthcare policymaker, delves into the transformative potential of GLP-1 drugs like Ozempic. He highlights their unexpected benefits for weight loss and other health issues, while addressing the ethical complexities surrounding accessibility and insurance coverage. Emanuel also shares insights on the future of cancer care and the impact of emerging technologies like AI in healthcare. His reflections on healthcare policy reveal crucial implications for equity and innovation in the U.S. healthcare system.

In this engaging discussion, Peter Diamandis, founder of the XPRIZE Foundation and author of the "Longevity Guidebook", explores the transformative potential of longevity science to potentially add decades of healthy living. Meanwhile, Ezekiel J. Emanuel, bioethicist and oncologist, raises concerns about government funding for such research and the ethical implications it entails. Together, they debate the balance between pursuing technological solutions and the vital importance of lifestyle choices for enhanced healthspan, leaving listeners pondering the future of aging and well-being.

The coronavirus pandemic isn’t over, but certain corners of Congress don’t want to spend a penny more on it. Dr. Ezekiel Emanuel argues for $100 billion in new spending to fight Covid-19.This episode was produced by Will Reid, edited by Matt Collette, engineered by Efim Shapiro, fact-checked by Laura Bullard, and hosted by Sean Rameswaram.Transcript at vox.com/todayexplainedSupport Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts Learn more about your ad choices. Visit podcastchoices.com/adchoices